Calcium D-Glucarate vs Resveratrol

Mechanism

Calcium D-glucarate is the calcium salt of D-glucaric acid, which is metabolized to D-glucaro-1,4-lactone (the active metabolite). This lactone inhibits beta-glucuronidase, the bacterial enzyme in the gut that deconjugates (cleaves) glucuronide conjugates from Phase II detoxification. By inhibiting beta-glucuronidase, calcium D-glucarate prevents the reabsorption (enterohepatic recirculation) of estrogen, environmental toxins, and carcinogens that were already conjugated for excretion. This effectively enhances the elimination of glucuronidated compounds, including estrogen metabolites, bilirubin, and xenobiotics.

Standard Dosing

500-1500mg daily

Timing

With meals, split 2-3x/day for sustained beta-glucuronidase inhibition.

Cycle Duration

ongoing or cycle with DIM protocol

Side Effects

• GI discomfort
• Loose stools
• Generally very well tolerated

Contraindications

• Pregnancy/lactation (estrogen clearance effects)
• Concurrent medications with narrow therapeutic index that undergo glucuronidation

Best Stacking Partners

Mechanism

Resveratrol activates SIRT1 (the longevity sirtuin) via allosteric binding, promoting deacetylation of PGC-1alpha (mitochondrial biogenesis), FOXO3 (stress resistance), and p53 (DNA repair). It inhibits NF-kB and COX-2, reducing chronic inflammation. Resveratrol also activates AMPK independently of SIRT1 and inhibits phosphodiesterases (PDEs), raising cAMP levels. It improves endothelial function via eNOS upregulation and NO production.

Standard Dosing

250-500mg trans-resveratrol daily

Timing

Morning with a fat-containing meal. Often taken alongside NMN for synergistic sirtuin activation.

Cycle Duration

ongoing

Side Effects

• GI upset/diarrhea at high doses
• Headache
• Joint pain (rare)
• Insomnia (if taken late)

Contraindications

• Estrogen-sensitive cancers (theoretical ER agonism)
• Bleeding disorders
• Pregnancy/lactation

Best Stacking Partners